Table 1. Baseline and selected characteristics of study patients by TICI scores.
TICI: Thrombolysis in Cerebral Infarction score; MCA: middle cerebral artery; IV tPA: intravenous tissue plasminogen activator.
| Table 1. Baseline and selected characteristics of study patients by TICI scores | ||||||||
| TICI Scores | ||||||||
| Variable | Total N=178 | Grade 0 n=17 | Grade 1 n=8 | Grade 2a n=24 | Grade 2b n=61 | Grade 3 n=67 | P-value | |
| Gender, n (%) | 0.41 | |||||||
| Male | 97 (54.5) | 12 (70.6) | 3 (33.3) | 14 (58.3) | 34 (55.7) | 32 (50.7) | ||
| Female | 81 (45.5) | 5 (29.4) | 6 (66.7) | 10 (41.7) | 27 (44.3) | 33 (49.3) | ||
| Race, n (%) | 0.15 | |||||||
| White | 110 (65.5) | 10 (62.5) | 8 (88.9) | 11 (47.8) | 37 (67.3) | 44 (67.7) | ||
| Black | 56 (33.3) | 5 (31.2) | 1 (11.1) | 11 (47.8) | 18 (32.7) | 21 (32.3) | ||
| Asian | 2 (1.2) | 1 (6.3) | 0 (0.0) | 1 (4.4) | 0 (0.0) | 0 (0.0) | ||
| Hemicraniectomy, n (%) | 4 (2.3) | 0 (0.0) | 0 (0.0) | 2 (8.3) | 1 (1.6) | 1 (1.5) | 0.41 | |
| Fraction of MCA territory | ||||||||
| infarcted, n (%) | 0.49 | |||||||
| < 1/3 | 68 (38.6) | 5 (29.4) | 1 (11.1) | 7 (29.2) | 24 (40.7) | 31 (46.3) | ||
| between 1/3 and 2/3 | 50 (28.4) | 6 (35.3) | 3 (33.3) | 8 (33.3) | 18 (30.5) | 15 (22.4) | ||
| > 2/3 | 58 (33.0) | 6 (35.3) | 5 (55.6) | 9 (37.5) | 17 (28.8) | 21 (31.3) | ||
| Stroke side | 0.72 | |||||||
| Left | 94 (54.3) | 8 (50.0) | 6 (66.7) | 14 (60.9) | 28 (48.3) | 38 (56.7) | ||
| Right | 79 (45.7) | 8 (50.0) | 3 (33.3) | 9 (39.1) | 30 (51.7) | 29 (43.3) | ||
| IV tPA, n (%) | 76 (48.4) | 8 (57.1) | 6 (85.7) | 12 (52.2) | 23 (43.4) | 27 (45.0) | 0.26 | |
| Smoking, n (%) | 91 (53.2) | 6 (35.3) | 1 (16.7) | 12 (50.0) | 31 (54.4) | 41 (61.2) | 0.12 | |
| Atrial fibrillation, n (%) | 35 (19.7) | 5 (29.4) | 1 (11.1) | 7 (29.2) | 11 (18.0) | 11 (16.4) | 0.51 | |
| Diabetes mellitus, n (%) | 32 (18.0) | 4 (23.5) | 1 (11.1) | 7 (29.2) | 11 (18.0) | 9 (13.4) | 0.45 | |
| Hypertension, n (%) | 100 (56.2) | 9 (52.9) | 4 (44.4) | 15 (62.5) | 30 (49.2) | 42 (62.7) | 0.50 | |
| Hyperlipedemia, n (%) | 51 (28.7) | 4 (23.5) | 2 (22.2) | 6 (25.0) | 22 (36.1) | 17 (25.4) | 0.64 | |
| Coronary artery disease, n (%) | 51 (28.7) | 4 (23.5) | 2 (22.2) | 6 (25.0) | 22 (36.1) | 17 (25.4) | 0.64 | |
| *p<0.05 statistically significant | ||||||||